ClinConnect ClinConnect Logo
Search / Trial NCT06110143

Oral Health and Adverse Pregnancy Complications

Launched by UNIVERSITY HOSPITAL BISPEBJERG AND FREDERIKSBERG · Oct 25, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called "Oral Health and Adverse Pregnancy Complications," is looking at how treating gum disease (periodontitis) during pregnancy can affect the health of both mothers and their babies. Gum disease is a common issue that can cause mild inflammation and has been linked to problems like preterm birth and low birth weight. The study aims to see if treating this condition can improve outcomes for pregnant women and their children, particularly in terms of fetal growth and the risk of early delivery.

To participate in this trial, pregnant women must be planning to give birth at either Holbaek or Nykoebing Falster hospital and have been diagnosed with a specific stage of gum disease by the study dentist. Women who do not have gum disease, have fewer than 20 healthy teeth, are already receiving treatment for gum disease, or have a more severe stage of gum disease are not eligible. If you qualify, you can expect to receive treatment for your gum disease during your pregnancy, and the researchers will monitor how this treatment affects you and your baby.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Pregnant women who are planned to give birth at either Holbaek or Nykoebing Falster hospital
  • Pregnant women diagnosed with periodontitis (stage I-III) by the study dentist
  • Exclusion Criteria:
  • Pregnant women without peridontitis
  • Pregnant women with less than 20 healthy teeths
  • Pregnant women with peridontitis and currently receiving treatment for peridontitis
  • Pregnant women with peridontitis stage IV

About University Hospital Bispebjerg And Frederiksberg

University Hospital Bispebjerg and Frederiksberg is a leading academic medical institution in Denmark, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge scientific inquiry with patient-centered care, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. The institution emphasizes a strong commitment to ethical standards and regulatory compliance, ensuring that all trials are designed to enhance medical knowledge and improve patient outcomes. With a focus on a wide range of therapeutic areas, University Hospital Bispebjerg and Frederiksberg strives to contribute significantly to the global medical community and the advancement of evidence-based practice.

Locations

Holbaek, , Denmark

Nykøbing Falster, , Denmark

Holbæk, Holbaek, Denmark

Patients applied

0 patients applied

Trial Officials

Berit Lilienthal Heitmann, Professor

Principal Investigator

University Hospital Bispebjerg and Frederiksberg

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported